Bruno Pereira
Sort By:
Year:
Note: This data was collect using the ISI Web of Science database.
 
Legend:
C - Citations
IF - Impact Factor
(*) Last Impact Factor reported
 
 
C
IF
1. Pereira B, Le Borgne M, Chartier NT, Billaud M, Almeida R
MEX-3 proteins: recent insights on novel post-transcriptional regulators. Trends in biochemical sciences 38: 477-9, 2013.  [Editorial Material] 
 
2. Pereira B, Sousa S, Barros R, Carreto L, Oliveira P, Oliveira C, Chartier NT, Plateroti M, Rouault JP, Freund JN, Billaud M, Almeida R
 doi: 10.1093/nar/gkt087 PMID: 23408853.
 
3. Tsai MH, Lin X, Shumilov A, Bernhardt K, Feederle R, Poirey R, Kopp-Schneider A, Pereira B, Almeida R, Delecluse HJ
 
4. Barros R, Pereira B, Duluc I, Azevedo M, Mendes N, Camilo V, Jacobs RJ, Paulo P, Santos-Silva F, van Seuningen I, van den Brink GR, David L, Freund JN, Almeida R
 doi: 10.1002/path.2369 PMID: 18498120.
 
5. Pereira B, Videira A, Duarte M
 
CDX2 promoter methylation is not associated with mRNA expression. International journal of cancer 125: 1739-42, 2009.  [Letter] 
 doi: 10.1002/ijc.24544 PMID: 19569237.
 
7. Barros R, Camilo V, Pereira B, Freund JN, David L, Almeida R
Pathophysiology of intestinal metaplasia of the stomach: emphasis on CDX2 regulation. Biochemical Society transactions 38: 358-63, 2010.  [Article; Proceedings Paper] 
 doi: 10.1042/BST0380358 PMID: 20298183.
 
8. Sadio A, Gustafsson JK, Pereira B, Gomes CP, Hansson GC, David L, Pêgo AP, Almeida R
 
9. Pereira B, Oliveira C, David L, Almeida R
CDX2 Promoter Methylation is not Associated with mRNA Expression Helicobacter 14: 385-385, 2009.  [Meeting Abstract] 
.
 
10. Camilo V, Barros R, Pereira B, Magalhaes A, Reis C, Freund J, David L, David L, Almeida R
BMP and H-pylori Downregulate SOX2 Expression in Gastric Cell Lines Helicobacter 14: 330-330, 2009.  [Meeting Abstract] 
.
 
Expression and Clinical Relevance of SOX9 in Gastric Cancer. Disease markers 2019: 8267021, 2019.  [Article] 
 
12. Pereira B, Billaud M, Almeida R
RNA-Binding Proteins in Cancer: Old Players and New Actors. Trends in cancer 3: 506-528, 2017.  [Review] 
 
Send Email
From
To
Subject